In follow-up research, we could devote ourselves to exploring the biological malignant function of CD3E and its regulatory mechanism on the tumor immune microenvironment in in vitro cell lines, in vivo animals, and large-scale multicenter LGG patients. Here, CD3E is linked to neoplasm.